Postdocs

Laura Perez Vidakovics

As a member of the CoroNAb project, I have been working on the expression, purification, and characterization of RBD domain and spike proteins of SARS-CoV-2. These were used for the immunization of animals and further selection of antibodies and nanobodies. In parallel, I have been working on the expression and characterization of nanobodies against SARS-CoV-2 and SARS-CoV-2 variant expansion and characterization in different cell lines. Previously working as assistant researcher at the University of La Plata (IBBM-CONICET), Argentina, on the project “Role of autophagy and ESCRTs machinery in replication of Junin virus (JUNV) and New World arenavirus (NWA)”.

Mykhailo Guzyk

Joined in Summer 2022 from the Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine in Kyiv, to continue his research in our lab partly funded by a grant from the Swedish Foundation for Strategic Research (SSF)

Hanna Bley

I joined the McInerney lab in October 2022 as a postdoctoral researcher after I obtained my PhD working on identifying cellular host factors for the Hepatitis C Virus in the lab of Prof. Dr. Eva Herker partially at the Leibniz Institute of Virology in Hamburg and The Philipps University or Marburg, Germany.
My current research focusses on understanding the alphavirus-host interplay as well as the human innate immune response as a first line of defense using MS-CETSA. This project has been funded by the Wenner-Gren Foundation.

Shirley Braspenning

I joined the lab in September 2025 as part of the VIGILANT consortium; in which I will focus on the role of cellular proteases during alphavirus infection. I’m broadly interested in virus-host interactions, particularly how viruses hijack and remodel cellular processes to support their replication. I received my PhD from the department of Viroscience at Erasmus MC, Rotterdam, where I studied VZV gene expression and latency. I then completed a postdoc at NYU Langone Health in New York City, investigating post-transcriptional regulation of HSV-1 latency .

Marie Peters

I obtained my bachelor’s degree in molecular life science from the University of Lübeck in Germany and my master's degree in molecular biology from Umeå University. Following this I pursued a PhD degree in virology in the Group of Anna Överby at Umeå University, successfully defending my thesis in 2025. I joined the McInerney group in October 2025 as a postdoctoral researcher to work on the role of different host factors in alphavirus infection.

PhD Student - Position to be filled

Starting Spring 2026